News & Articles

Explore CN Bio's innovative gut/liver-on-a-chip solution, empowering researchers to accurately profile human oral drug bioavailability in vitro

Strategic partnership harnesses respective organ-specific expertise to provide complete human-derived organ-on-a-chip solution for more accurate in vitro ADME predictions

The PhysioMimix HT system has been designed to increase productivity, cost-effectiveness and data robustness

Expansion of five-year collaboration broadens established organ-on-a-chip research demonstrating advanced performance of the PhysioMimix MPS

First product within new ‘in-a-box’ range, which harnesses next-generation, human-relevant Liver-on-a-Chip technology to improve the accuracy and efficiency of NASH drug discovery

New partnership will focus on validation of novel organ-on-a-chip infection models to develop the next generation of COVID-19 research tools

This new oncology service supports unique in vitro investigations into the PK/PD relationship

The tool enables accurate modelling of the human colon and the mucosal barrier

The provision of high-quality cells that are known to grow successfully in 3D culture will help fast track organ-on-a-chip (OOC) adoption and customer research

The next-generation organ-on-a-chip technology to be used to investigate the human gut microbiome for improving outcomes for patients with liver cirrhosis

Extension aims to evaluate CN Bio’s PhysioMimix lung-on-a-chip platform in addition to deepening existing research collaboration for liver studies

The next-generation organ-on-a-chip technology enables pre-clinical studies that simulate complex interaction and communication between organs

Funding will advance 3D lung cell culture models to accelerate drug discovery

Extended range of services supports accelerated drug discovery and development using predictive 3D Liver-on-Chip technology